Term ends Feb 27, 2030 · High confidence
20-year base term ends Feb 5, 2030
Held by Schott Pharma Schweiz AG and Schott Pharma AG & Co. KGaA
Filed Mar 28, 2013 as application 13/852,039 · Granted Aug 18, 2015
Base term plus 22 days of patent term adjustment (USPTO delay)
Today
2010
2030
Clock starts
Feb 5, 2010
Feb 5, 2010
Term ends
Feb 27, 2030
Feb 27, 2030
Granted
Aug 18, 2015
Aug 18, 2015
base term
patent term adjustment
fee events
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
22
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 8,158,225, to Feb 27, 2030. The term already ends on or before that date, so the cap shortened nothing.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
2
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 22 days past its 20-year base term on prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Feb 5, 2010, when application 12/700,762, the earliest non-provisional in its chain, was filed (this one was filed Mar 28, 2013) | Feb 5, 2030 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +22 days, USPTO patent term adjustment record | Feb 27, 2030 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 8,158,225) | resolves to Feb 27, 2030, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Feb 27, 2030 | High confidence |
This family
| US 8,464,553 | In force Apr 2031 | Apr 2031 |
| US 9,107,805 | this patent Feb 2030 | Feb 2030 |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Nov 21, 2022 Reel 61972, frame 280 | Schott AG | Schott Pharma AG & Co. KGaA | Assignment of Assignor's Interest |
| Nov 20, 2023 reel/frame not recorded | Schott Pharma AG & Co. KGaA | Schott Pharma Schweiz AG | Assignment of Assignor's Interest |
| Nov 20, 2023 reel/frame not recorded | Schott Pharma AG & Co. KGaA | Schott Pharma AG & Co. KGaA | Assignment of Assignor's Interest |
| Nov 20, 2023 Reel 65625, frame 322 | Schott Pharma AG & Co. KGaA | Schott Pharma Schweiz AG; Schott Pharma AG & Co. KGaA | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Feb 2030
Term ends Feb 27, 2030. Maintenance fees still fall due before then
Note
The 22 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 8,158,225, ends no earlier than this term, so it caps nothing.
Citations
19
later US patents cite this one
That is top 25% of utility patents granted in 2015 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.